Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Are there differences in effectiveness between topical anti-inflammatory treatments (steroids, calcineurin inhibitors, or lithium salts) and placebo or azoles in the treatment of seborrheic dermatitis of the face and scalp in adults?
The topical anti-inflammatory treatments were more effective in achieving total clearance of symptoms than placebo by 1.4-fold to 8.5-fold, but there are no considerable differences in the anti-inflammatory topical treatments or in comparison with azoles for short-term treatment. There is no evidence of treatment effects in long-term, continuous, or intermittent use of these compounds despite the chronic nature of the disease.
Kastarinen H, Okokon EO, Verbeek JH. Topical Anti-inflammatory Agents for Seborrheic Dermatitis of the Face or Scalp: Summary of a Cochrane Review. JAMA Dermatol. 2015;151(2):221–222. doi:10.1001/jamadermatol.2014.3186
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: